Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy

Experimental Nephrology

Volumn 6, Issue 2, 1998, Pages 121-131

  Zoja, Caria ^a   Liu, Xue Hui ^a   Abbate, Mauro ^a   Coma, Daniela ^a   Schiffrin, Ernesto L ^c   Remuzzi, Giuseppe ^a,b   Benigni, Ariela ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin II receptor antagonist; Angiotensin converting enzyme inhibitor; Eudothelins; Immunohistochemistry; Nonisotopic in situ hybridization; Passive Heymann nephritis; Protein overload; Tubular reabsorption

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ENDOTHELIN 1; LISINOPRIL; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; GLOMERULUS BASEMENT MEMBRANE; IN SITU HYBRIDIZATION; KIDNEY TUBULE ABSORPTION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAT; URINARY EXCRETION;

EID: 0031952293     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020519     Document Type: Article

References (31)

1. Onsio S, Benigni A, Bruzzi I, Coma D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993;43:354-358.
2. Zoja C, Corna D, Bruzzi I, Fogliem C, Bertani T, Remuzzi G, Benigni A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuna and retards renal structural injury. Exp Nephrol 1996;4:213-221.
3. Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Yomino Y, Koide H: Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J Lab Clin Med 1994;123:763-768.
4. Ohia K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, Marumo F: Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 1991;39:307-311.
5. Remuzzi G: Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 1995;4:339-342.
6. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
7. Ong AC, Jowett TP, Moorhead JF, Owen JS: Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. Kidney Int 1994;46:1315-1321.
8. Achmad TH, Rao GS: Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel; blockers. Biochem Biophys Res Commun 1992;189:994-1000.
9. Ong ACM. Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: A new paracrine loop implicated in human tubulo-interstitial fibrosis: Tubular-derived endothelms modulate renal interstitial fibroblast function (abstract). J Am Soc Nephrol 1993;4:473.
10. Benigni A, Remuzzi G: Glomerular protein trafficking and progression of renal disease to terminal uremia. Semin Nephrol 1996;16:151-159
11. Fox J, Guan S, Hymel AA, Navar LG: Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 1992;262:F902-F909.
12. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991;18:763-773.
13. Zoja C, Corna D, Facchinetti D, Maffi R, Luzzana E, Benani T, Remuzzi G: Combining ACE inhibition and angiotensin II (AII) receptor blocking stops renal disease progression in experimental membranous nephropathy (MN) (abstract). J Am Soc Nephrol 1995;6:860.
14. Edgington TS, Glassock RJ, Watson JI, Dixon FJ: Characterization and isolation of specific renal tubular epithelial antigens. J Immunol 1967;99:1199-1210.
15. Siegl PIC Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ: In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol ExpTher 1992;262:139-144.
16. Abbate M, Bachinsky D, Zheng G, Sramenkovic I, McLaughlin M, Niles JL, McCluskey RT, Brown D: Location of gp330/α2-m receptor-associated protein (α2-MRAP) and its binding sites in kidney Distribution of endogenous α2-MRAP is modified by tissue processing. Eur J Cell Biol 1993;61:139-149.
17. Pfeffer JM, Pfeffer MA, Fröhlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971;78:957-962.
18. Read SM, Nonhcote DH: Minimization of variation m the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 1981;116:53-64.
19. Benigm A, Perico N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, Remuzzi G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 1991;260:F331-F339.
20. Perico N, Amuchastegui CS, Malanchini B, Benani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 1994;2:220-228.
21. Highashi A, Peters L: A rapid colorimetric method for the determination of inulin in plasma and urine. J Lab Clin Med 1950;35:475-480.
22. Smith HW, Finkelstein N, Aliminosa L, Crawford B: The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
23. Larivièere R, Day R, Schiffrin EL: Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993;21:916-920.
24. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G: Age-related nephropathy and proteinuna in rats with intact kidneys exposed to diets with different protein contents. Lab Invest 1989;60:196-204.
25. Wilkes BM, Susm M, Memo PF, Macica CM, Girardi EP, Boss E, Nord EP: Localization of endothelin-like immunoreactivity in rat kidneys. Am J Physiol 1991;260:F913-F920.
26. MacCumber MW, Ross CA, Glaser BM, Synder SH: Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989;86:7285-7289.
27. Ujiie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, Marumo F: Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 1992;90:1043-1048.
28. Chen M, Todd-Turla K, Wang W-H, Cao X, Smart A, Brosius FC, Killen PD, Keiser JA, Briggs JP, Schnermann J: Endotheiin-1 mRNA in glomerular and epithelial cells of kidney. Am J Physiol 1993;265:F542-F550.
29. Helset E, Sildnes T, Seljelid R, Konopski ZS: Endothelm-1 stimulates human monocytes in vitro to release TNF-β, IL-1β and IL-6. Mediators Inflamm 1993;2:417-422.
30. Schnermann JB, Zhu XL, Shu X, Yang T, Huang YG, Kretzler M, Briggs JP: Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 1996;137:5000-5008.
31. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzvme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensm II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 1997;29:254-264.